These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3804148)

  • 1. [Therapy of drug-resistant ventricular arrhythmias].
    Lessem JN; Hamby RA
    Fortschr Med; 1986 Nov; 104(41):784-6. PubMed ID: 3804148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute cardiac arrhythmias using adrenergic beta blockaders. Experience with sotalol].
    Martín Jadraque L; Liste Jiménez D; González Maqueda I; Del Rio Bustos A
    Rev Esp Cardiol; 1975; 38(2):153-62. PubMed ID: 1135483
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term sotalol therapy in patients with ventricular arrhythmias.
    Mary-Rabine L; Soumagne D; Stiels B
    Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study.
    Burckhardt D; Pfisterer M; Hoffmann A; Burkart F; Emmenegger H; Jost M; Bolli P; Buehler FR
    Cardiology; 1983; 70 Suppl 1():114-21. PubMed ID: 6342778
    [No Abstract]   [Full Text] [Related]  

  • 5. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
    Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
    Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine in ventricular arrhythmias--an assessment by 24 hours holter monitoring.
    Gambhir DS; Khalilullah M; Bahl VK
    Indian Heart J; 1984; 36(3):142-6. PubMed ID: 6490043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
    Wehr M
    Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing.
    Blomström-Lundqvist C; Dohnal M; Hirsch I; Lindblad A; Hjalmarson A; Olsson SB; Edvardsson N
    Br Heart J; 1986 Feb; 55(2):181-6. PubMed ID: 3080012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
    Kirschenbaum HL; Rosenberg JM
    Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory management of ventricular arrhythmias.
    Morganroth J
    Med Times; 1980 Jan; 108(1):42-6. PubMed ID: 7374399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the antiarrhythmic effects of Sotalol given orally].
    Fauchier JP; Neel C; Garabedian V; Cosnay P; Brochier M
    Ann Cardiol Angeiol (Paris); 1982 Jun; 31(4):329-38. PubMed ID: 7137863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between ventricular function and antiarrhythmic responses to sotalol.
    Singh SN; Chen YW; Cohen A; Obeid M; Tracy C; Woosley RL; Fletcher RD
    Am J Cardiol; 1989 Oct; 64(14):943-5. PubMed ID: 2801566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sotalol--pharmacology, effect on hemodynamics and interactions].
    Nyznyk M; Walczak F; Jodkowska-Skarzyńska M; Kulicka D
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):321-3. PubMed ID: 8415246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 18. Sotalol marketed for life-threatening arrhythmias.
    Clin Pharm; 1993 Mar; 12(3):176. PubMed ID: 8491074
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-adrenergic blockade with INPEA in arrhythmia].
    Cárdenas M; Nadal B; Sanz G
    Arch Inst Cardiol Mex; 1971; 41(1):74-85. PubMed ID: 4942627
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sotalol].
    Hohnloser SH
    Internist (Berl); 1995 Feb; 36(2):170-3; discussion 174. PubMed ID: 7737808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.